Successful conservative treatment of a mandibular unicystic ameloblastoma : 13-year follow-up by Isolan, Cristina-Pereira et al.
J Clin Exp Dent. 2018;10(11):e1123-6.                                                                                                                        Successful conservative treatment of a unicystic ameloblastoma
e1123
Journal section: Oral Medicine and Pathology                         
Publication Types: Case Report
Successful conservative treatment of a mandibular 
unicystic ameloblastoma: 13-year follow-up 
Cristina-Perira Isolan 1, Andressa-Goicochea Moreira 1, Adriana Edges 1, Leticia-Kirst Post 1,2, Juan-Pablo 
Aitken-Saavedra 1,3
1 Post Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, Brazil
2 Department of Surgery and Maxillofacial Traumatology, School of Dentistry, Federal University of Pelotas, Pelotas Brazil
3 Department of Oral Pathology and Medicine, School of Dentistry, University of Chile, Santiago, Chile 
Correspondence:
School of Dentistry
Federal University of Pelotas
Rua Gonçalves Chaves
457, 96015-560, Pelotas, RS, Brazil
juanpabloaitken@gmail.com




Ameloblastoma is an uncommon, locally aggressive benign odontogenic tumor and can reach considerable dimen-
sions causing facial deformity and functional impairment. They are characterized by local aggressiveness. It is 
recommended that maxillary ameloblastomas be treated aggressively due to proximity of various vital structures. 
Conservative treatments such as marsupialization, enucleation and curettage while preserving bone integrity seem 
to be associated with a high rate of recurrence. Treatment evaluation of ameloblastomas is a complex issue, as idea-
lly it should not be so destructive due to the benign nature of this lesion, but should be extensive enough to avoid 
recurrences. The present study is about a clinical case of a 16-year- old man with a unicystic ameloblastoma treated 
successfully with marsupialization. Patient was followed up every 12 months. About 13 years after diagnosis, the 
patient is clinically healthy and radiographically it is possible to observe evidence of bone repair.




Ameloblastoma is an uncommon, locally aggressive 
benign odontogenic tumor and can reach considerable 
dimensions causing facial deformity and functional im-
pairment. Corresponds to approximately 10% of tumors 
affecting the mandible and maxilla. It is usually found 
in young adults, reaching equally men and women, with 
peak incidence in the third and fourth decade of life and 
is most often found in the body and branch of the mandi-
ble, but can occur anywhere in the mandible or jaw (1). 
When intraosseous, ameloblastomas can be classified as 
multicystic / solid or unicystic. The multicystic / solid 
is more common, aggressive and has a higher rate of 
recurrence after surgery (2).
Unicystic ameloblastoma is a variant of ameloblastoma 
with a relatively benign biologic behavior and better res-
ponse to conservative treatment. It mostly occurs in a 
younger age group, the predominant location is the man-
dible, is radiologically unilocular, and is histologically 
characterized as a cystic lesion lined by an ameloblasto-
matous epithelial lining (2,3). Histologically, unicystic 
ameloblastoma is categorized into luminal, intraluminal, 
and mural subtypes and recurrence rate is less than 25% 
for all types of unicystic ameloblastomas. Although the 
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unicystic is less aggressive than multicystic / solid and 
may respond well to enucleation and curettage (3), it is 
recommended that ameloblastomas in the jaws in gene-
ral, be treated aggressively due to proximity of various 
vital structure (2).
In general, ameloblastomas are characterized by local 
aggressiveness. Conservative treatments such as marsu-
pialization, enucleation and curettage, while preserving 
bone integrity and allowing continuous growth of the 
mandible (4) seem to be associated with a high rate of 
recurrence. Some articles report 90% recurrence rates 
for ameloblastomas that were not treated radically (5). 
Treatment evaluation of ameloblastomas is a complex 
issue, as ideally it should not be so destructive due to 
the benign nature of this lesion, but should be extensive 
enough to avoid recurrences. Several studies have repor-
ted a higher rate of recurrence after conservative treat-
ment compared to radical treatment (6,7). 
The therapeutic approach of ameloblastoma should be 
analyzed after a thorough analysis of different histolo-
gical factors, clinical characteristics and behavior of the 
lesion. The most appropriate treatment is resection with 
a margin of 1-1.5 cm apparently unbound bone (8). Ca-
ses treated surgically can present a serious psychological 
trauma for those affected (4). The present study is a cli-
nical case of a unicystic ameloblastoma treated success-
fully with marsupialization and whose follow-up after 
13 years, is evident bone repair, without recurrences.
Case Report
A 16-year-old man with no systemic diseases, resident 
of the city of São Lourenço, Rio Grande do Sul, Brazil, 
sought a dental surgeon for the endodontic treatment of 
the tooth 47. Radiographs were requested in Decem-
ber 2004 and was observed a well delimited unilocular 
lesion associated with impacted tooth 48 (Fig. 1). The 
man was referred to a specialist in oral and maxillofa-
cial surgery in the city of Pelotas, RS, before endodontic 
treatment. 
Fig. 1: Panoramic radiography performed before marsupialization of 
the lesion in which the presence of the radiolucent, unilocular lesion 
associated to the tooth is observed 48.
Fig. 2: A) (4X). Histologic analysis revealed a cystic cavity lined partially coated by non-keratinized fine odontogenic epithelium with two 
to four layers of rounded and flattened cells, in which the basal cells were columnar, hyperchromatic, and palisaded and reversed polarity. B) 
(10X) and 2C (20X). Histologic analysis revealed nests and islands with ameloblastic characteristics permeated the capsular tissue of dense 
fibrous connective tissue.
The marsupialization of the lesion and an incisional 
biopsy was performed and histologic analysis revealed 
dentigerous cyst. Three months later the endodontic 
treatment of the tooth 47 was made. After nine months, 
the lesion was completely removed and the biopsy was 
sent for histopathological analysis in Center of Diagno-
sis of Diseases of the Mouth, Federal University of Pe-
lotas, Brazil (CDDB-FO / UFPEL). Histologic analysis 
revealed unycistic mural ameloblastoma (Fig. 2A-C). 
Approximately 3 months after tooth 48 extraction and 
total removal of the lesion, it was possible to observe a 
mineralize d aspect compatible with the normal repair 
process of the region. Patient was followed up every 12 
months. The tooth 47 was extracted. Currently, the pa-
tient is clinically healthy. In panoramic x-rays at 5 (Fig. 
3A) and 13 years (Fig. 3B) after diagnosis it is possible 
to observe evidence of bone repair.
 
Discussion
It is well known that the therapeutic management of 
ameloblastomas is a complex issue as the surgery should 
be invasive/aggressive to avoid subsequent recurrence. 
The conservative approach may consist of enucleation 
or curettage, sometimes preceded by marsupialization 
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Fig. 3: A) Panoramic radiography showing aspect of normality in the area repair process after 7-year follow-up. B) Panoramic radiography 
showing aspect of normality in the area repair process after 13-year follow-up.
(9). The rate of recurrence after conservative treatment 
is a problem which has not yet been solved. Neverthe-
less, this study showed a successfully marsupialization 
treatment of an unicystic ameloblastoma with evidence 
of bone repair after 13 years in a sixteen years old young 
man. 
The decision of the type of treatment of an ameloblas-
toma, should consider the histological pattern, clinical 
characteristics and behavior of the lesion, in the maxi-
llary bones, size, age of the patient among other factors 
(5). However, it is established that the most appropriate 
treatment to prevent recurrences and possible more ag-
gressive surgeries in the future is bone resection with a 
margin of 1-1.5 cm of apparently unaffected bone (8). It 
is important establish the histological subtype of amelo-
blastoma to decide an adequate treatment. It is also pos-
sible to establish erroneously, diagnosis of dentigerous 
cyst due to its histological similarity as it happened in 
this case. This diagnostic difficulty has been discussed in 
the literature (10) The luminal and intraluminal varieties, 
limited by a fibrous wall constituted by fibrous connecti-
ve tissue, can be eliminated completely with a relatively 
good prognosis. For mural pattern (like this case) and 
invasive cases, it is recommended to perform surgeries 
with a wide margin of safety because ameloblastomas 
invade the trabecular spaces of bone (5, 9). Some studies 
provide evidence that Conservative treatments for uni-
cystic ameloblastomas like marsupialization in young 
patients have advantages and is effective in regressing 
the lesion size, ease complete removal and preserving 
osseous growth (11). Some studies have evaluated more 
conservative therapies with good results and where it is 
suggested to start with this modality before performing 
more aggressive surgeries (12). However, there is little 
evidence there has been a follow up for as many years 
as this study reports. Enucleation is not an adequate 
treatment for solid and multicystic ameloblastomas due 
to the high rate of recurrence (60-80%). In those cases, 
more aggressive treatments are more indicated. It ha-
ppens that sometimes the subtypes of ameloblastomas 
cannot be identified, therefore a more radical surgery is 
recommended (3). In a study performed in patients with 
ameloblastoma, no recurrence was observed in 11 initia-
lly treated with radical resection while recurrences were 
observed in 22 cases initially treated with conservative 
therapy (13). According to Sampson et al. (14), when 
recurrence is present, extensive surgery is usually requi-
red. The case presented is in agreement with reports of 
ameloblastomas successfully treated conservatively in 
young people. Huang et al. (15) conducted a study in 15 
patients with ameloblastoma, under 18, concluding that 
good results can be obtained with conservative surgery 
and that in case of recurrence, a second surgery can be 
successful. However, careful monitoring is very impor-
tant. In this study case, they were 13 years of follow-up 
thus the chances of recurrence are very low.
Ameloblastomas remain one of the most controversial 
lesions in relation to the type of treatment. In order to 
decide, it should be considered the localization, size and 
histological type among other factors. Nevertheless, it 
is accepted that resection with safety margin is the best 
treatment to prevent recurrence. Although the evidence 
goes against, regarding treatment in ameloblastomas in 
general this study coincides with successful cases that 
evaluated conservative therapies in unycistics amelo-
blastomas (11), considered a less aggressive form of 
ameloblastomas and could be successfully treated by 
simple enucleation or less aggressive surgery. Further-
more, in the literature, recurrence after conservative 
treatment in this type of ameloblastomas is reported to 
be between 10 and 25%, however these reports do not 
specify the histological subtypes of the primary lesion. 
Due to this, on several occasions is choose resection as 
treatment, which may be unnecessary (3) In this case, it 
was demonstrated that conservative therapy in a young 
patient, not only preserved the bone structures in good 
condition, but also saved the patient from psychological 
trauma resulting from aggressive surgery. 
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